Sagefield Capital’s Eucrates Biomedical Acquisition Corp. Warrant EUCRW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,666
Closed 150
2022
Q2
$0 Hold
2,666
﹤0.01% 150
2022
Q1
$0 Hold
2,666
﹤0.01% 158
2021
Q4
$2K Buy
+2,666
New +$2K ﹤0.01% 158